Showing results (51-60 of 378) with videos related to
Sort By:
Pageof 38
The Journal of Clinical Investigation|November 3, 2011
Ceramides as modulators of cellular and whole-body metabolismBenjamin T Bikman, Scott A SummersNature Reviews. Endocrinology|November 4, 2016
Sphingolipids and phospholipids in insulin resistance and related metabolic disordersPeter J Meikle, Scott A SummersArchives of Biochemistry and Biophysics|November 1, 2003
Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubesJose Antonio Chavez, Scott A SummersDiabetes|March 1, 2005
A role for sphingolipids in producing the common features of type 2 diabetes, metabolic syndrome X, and Cushing's syndromeScott A Summers, Don H NelsonBiochimica Et Biophysica Acta|October 3, 2009
Lipid oversupply, selective insulin resistance, and lipotoxicity: molecular mechanismsJose Antonio Chavez, Scott A SummersThe American Journal of Clinical Nutrition|April 29, 2004
Skeletal muscle lipid concentration quantified by magnetic resonance imagingBret H Goodpaster, V Andrew Stenger, Fernando Boada, et al.Diabetes|December 24, 2004
Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetesVladimir B Ritov, Elizabeth V Menshikova, Jing He, et al.Reviews in Endocrine & Metabolic Disorders|January 20, 2025
Poor muscle quality: A hidden and detrimental health condition in obesityFlavio T Vieira, Yuanjun Cai, M Cristina Gonzalez, et al.The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|June 27, 2006
Effects of exercise on mitochondrial content and function in aging human skeletal muscleElizabeth V Menshikova, Vladimir B Ritov, Liane Fairfull, et al.Frontiers in Endocrinology|August 28, 2020
Too Much of a Good Thing? An Evolutionary Theory to Explain the Role of Ceramides in NAFLDAnnelise M Poss, Scott A SummersPageof 38